SHAILY Shaily Engineering Plastics Q3 FY26 results (Oct–Dec 2025) and concall
Shaily Engineering Plastics delivered strong Q3 FY26 results with revenue growing 27% YoY and EBITDA up 43% YoY, primarily driven by robust performance in the Healthcare segment. The company announced a strategic new facility in Abu Dhabi to significantly expand pen/auto-injector capacity and appointed a new COO for its Healthcare division. While the Consumer segment faced degrowth, management expects a rebound, and new capacity additions in India are progressing despite qualification delays.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 26.9%, net profit up 100.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 180 | 186 | 203 | 225 | 236 +31% | 236 +27% |
| EBITDA | 31 | 38 | 48 | 61 | 68 +119% | 64 +68% |
| Net profit | 13 | 18 | 30 | 36 | 41 +215% | 36 +100% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
